Role of 6-amino flavone in attenuating cisplatin induced neurotoxicity via inhibition of p-JNK signaling pathway in post-natal day-7 mice

Main Article Content

Latafat Kahkashan Ahmad
Rifat Jahan
Amin Jan
Shahid Ali Shah


OBJECTIVE:  To investigate the protective role of 6-amino flavone (6-AF) in cisplatin-induced neuro-inflammation in the developing brains of post-natal day-7 (PND-7) mice.

METHODS: This experimental study, conducted at the Neuro Molecular Medicines Research Center in Peshawar, Pakistan, included 20 PND-7 mice from January to March 2023. PND-7 mice were randomly distributed into four groups, a control group, a cisplatin group, a cisplatin + 6-AF group, and a 6-AF group. Cisplatin was administered intraperitoneally at a dose of 20 mg/kg to the cisplatin group. 6-AF was injected at a dose of 30 mg/kg after cisplatin administration to cisplatin+6-AF group and 6-AF group mice. After 4 hours of the drug treatment, all the PND-7 mice were sacrificed for Western blot analysis. ImageJ software was used for the densitometry of the blots. One-way ANOVA and post-hoc Tukey tests through Prism Graph-5 were applied for statistical analysis.   

RESULTS: Significant differences in p-JNK levels along with TNF-α, NF-κB, and IL-1β proteins were observed in the brain homogenates of PND-7 mice in various groups. A post-hoc Tukey test revealed a significant increase (p<0.001) in the p-JNK, COX-2, NF-κB, and IL-1β levels in the cisplatin group as compared to control group mice. However, a significant decrease (p<0.001) was observed in p-JNK, COX-2, NF-κB, and IL-1β expression levels in the cisplatin + 6-AF group as compared to the cisplatin group.

CONCLUSION: Administration of 6-AF effectively reduced cisplatin-induced neurotoxicity in PND-7 mice, demonstrating a neuroprotective effect by suppressing p-JNK and its downstream TNF-α, NF-κB, and IL-1β proteins.

Article Details

How to Cite
Ahmad, L. K., R. Jahan, A. Jan, and S. A. Shah. “Role of 6-Amino Flavone in Attenuating Cisplatin Induced Neurotoxicity via Inhibition of P-JNK Signaling Pathway in Post-Natal Day-7 Mice”. KHYBER MEDICAL UNIVERSITY JOURNAL, vol. 16, no. 1, Mar. 2024, pp. 45-51, doi:10.35845/kmuj.2024.23461.
Original Articles


Yan D, An G, Kuo MT. C-Jun N-terminal kinase signalling pathway in response to cisplatin. J Cell Mol Med 2016;20(11):2013-19.

Lu RM, Hwang YC, Liu IJ, Lee CC, Tsai HZ, Li HJ, et al. Development of therapeutic antibodies for the treatment of diseases. J Biomed Sci 2020;27(1):1-30.

Aldossary SA. Review on pharmacology of cisplatin: Clinical use, toxicity and mechanism of resistance of cisplatin. Biomed Pharmacol J 2019;12(1):7-15.

Feliu J, Heredia-Soto V, Gironés R, Jiménez-Munarriz B, Saldaña J, Guillén-Ponce C, et al. Management of the toxicity of chemotherapy and targeted therapies in elderly cancer patients. Clin Transl Oncol 2020;22:457-67.

Gwathmey KG. Sensory neuronopathies. Muscle Nerve 2016;53(1):8-19.

Cankara FN, Günaydın C, Çelik ZB, Şahin Y, Pekgöz Ş, Erzurumlu Y, et al. Agomelatine confers neuroprotection against cisplatin-induced hippocampal neurotoxicity. Metab Brain Dis 2021;36(2):339-49.

Rottenberg S, Disler C, Perego P. The rediscovery of platinum-based cancer therapy. Nat Rev Cancer 2021;21(1):37-50.

Romani AMP. Cisplatin in cancer treatment. Biochem Pharmacol 2022;206:115323.

Guven H, Arici A, Simsek O. Flavonoids in our foods: A short review. J Basic Clin Health Sci 2019;3(2):96-106.

Patel DK. Pharmacological activities and therapeutic potential of kaempferitrin in medicine for the treatment of human disorders: A review of medicinal importance and health benefits. Cardiovasc Haematol Disord Drug Targets 2021;21(2):104-14.

Souiei S, Bouajila J, Saidi I, Znati M, Jannet HB, El Garah F. Synthesis, in vitro and in silico evaluation of new flavonoids-trifluoroacetylated amino acid conjugates as anti-acetylcholinesterase and anti-proliferative agents. J Mol Struct 2023;1292:136180.

Shah SA, Khan M, Jo MH, Jo MG, Amin FU, Kim MO. Melatonin Stimulates the SIRT 1/Nrf2 signaling pathway counteracting lipopolysaccharide (LPS)-induced oxidative stress to rescue postnatal rat brain. CNS Neurosci Ther 2017;23(1):33-44.

Volarevic V, Djokovic B, Jankovic MG, Harrell CR, Fellabaum C, Djonov V, et al. Molecular mechanisms of cisplatin-induced nephrotoxicity: A balance on the knife edge between renoprotection and tumor toxicity. J Biomed Sci 2019;26(1):1-14.

Jayaram, S, Krishnamurthy PT. Role of microgliosis, oxidative stress and associated neuroinflammation in the pathogenesis of parkinson’s disease: The therapeutic role of Nrf2 activators. Neurochem Int 2021;145:105014.

Qi L, Luo Q, Zhang Y, Jia F, Zhao Y, Wang F. Advances in toxicological research of the anticancer drug cisplatin. Chem Res Toxicol 2019;32(8):1469-86.

Cao M, Liu F, Ji F, Liang J, Liu L, Wu Q, et al. Effect of C-Jun N-terminal kinase (JNK)/P38 mitogen-activated protein kinase (P38 MAPK) in morphine-induced tau protein hyperphosphorylation. Behav Brain Res 2013;237:249-55.

Xie X, Kaoud TS, Edupuganti R, Zhang T, Kogawa T, Zhao Y, et al. C-Jun N-terminal kinase promotes stem cell phenotype in triple-negative breast cancer through upregulation of notch1 via activation of C-Jun. Oncogene 2017;36(18):2599-608.

Nailwal NP, Doshi GM. Role of intracellular signaling pathways and their inhibitors in the treatment of inflammation. Inflammopharmacology 2021;29(3):617-40.

Sharma VK, Singh TG, Singh S, Garg N, Dhiman S. Apoptotic pathways and alzheimer’s disease: Probing therapeutic potential. Neurochem Res 2021;46:3103-22.

Wang T, He C. Pro-inflammatory cytokines: The link between obesity and osteoarthritis. Cytokine Growth Factor Rev 2018;44:38-50.

Chen L, Deng H, Cui H, Fang J, Zuo Z, Deng J, et al. Inflammatory responses and inflammation-associated diseases in organs. Oncotarget 2018;9(6):7204-18.

Sun W, Zhang N, Liu B, Yang J, Loers G, Siebert HC, et al. HDAC3 inhibitor RGFP966 ameliorated neuroinflammation in the cuprizone-induced demyelinating mouse model and LPS-stimulated BV2 cells by downregulating the P2X7R/STAT3/NF-κB65/NLRP3 activation. ACS Chem Neurosci 2022;13(17):2579-98.

Jha AK, Gairola S, Kundu S, Doye P, Syed AM, Ram C, et al. Toll-like receptor 4: An attractive therapeutic target for acute kidney injury. Life Sci 2021;271:119155.

Fang C, Lou D, Zhou L, Wang J, Yang B, He Q, et al. Natural products: Potential treatments for cisplatin-induced nephrotoxicity. Acta Pharmacol Sin 2021;42(12):1951-69.

Suzdaltseva Y, Goryunov K, Silina E, Manturova N, Stupin V, Kiselev SL. Equilibrium among inflammatory factors determines human MSC-mediated immunosuppressive effect. Cells 2022;11(7):1210.

Saral S, Topçu A, Alkanat M, Mercantepe T, Akyıldız K, Yıldız L, et al. Apelin-13 activates the hippocampal BDNF/TrkB signaling pathway and suppresses neuroinflammation in male rats with cisplatin-induced cognitive dysfunction. Behav Brain Res 2021;408:113290.

Wen L, Tao S, Guo F, Li L, Yang H, Liang Y, et al. Selective EZH2 inhibitor Zld1039 alleviates inflammation in cisplatin-induced acute kidney injury partially by enhancing RKIP and suppressing NF-κB P65 pathway. Acta Pharmacol Sin 2022;43(8):2067-80.

Afshari AR, Sanati M, Mollazadeh H, Kesharwani P, Johnston TP, Sahebkar A. Nanoparticle-based drug delivery systems in cancer: A focus on inflammatory pathways. Semin Cancer Biol 2022;86:860-72.

Qin X, Meghana K, Sowjanya NL, Sushma KR, Krishna CG, Manasa J, et al. Embelin attenuates cisplatin-induced nephrotoxicity: Involving inhibition of oxidative stress and inflammation in addition with activation of Nrf-2/Ho-1 pathway. Biofactors 2019;45(3):471-8.

Wang T, He C. Pro-inflammatory cytokines: The link between obesity and osteoarthritis. Cytokine Growth Factor Rev 2018;44:38-50.

Lei CQ, Wu X, Zhong X, Jiang L, Zhong B, Shu HB. USP19 inhibits TNF-α–and IL-1β–triggered NF-κB activation by deubiquitinating TAK1. J Immunol 2019;203(1):259-68.

Liu Y, Yang Y, Zhang C, Huang F, Wang F, Yuan J, et al. Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Sci China Life Sci 2020;63(3):364-74.

Lu L, Liu W, Li S, Bai M, Zhou Y, Jiang Z, et al. Flavonoid derivative DMXAA attenuates cisplatin-induced acute kidney injury independent of STING signaling. Clin Sci (Lond) 2023;137(6):435-52.

Altindağ F. Silymarin ameliorates cisplatin-induced nephrotoxicity by downregulating TNF-α and NF-kB and by upregulating IL-10. J Exp Clin Med 2022;39(1):216-20.

Alsayari A, Muhsinah AB, Hassan MZ, Ahsan MJ, Alshehri JA, Begum N. Aurone: A biologically attractive scaffold as anticancer agent. Eur J Med Chem 2019;166:417-31.

Naeimi AF, Alizadeh M. Antioxidant properties of the flavonoid fisetin: An updated review of in vivo and in vitro studies. Trends Food Sci Technol 2017;70:34-44.

Li AL, Li GH, Li YR, Wu XY, Ren DM, Lou HX, et al. Lignan and flavonoid support the prevention of cinnamon against oxidative stress related diseases. Phytomedicine 2019;53:143-53.